Dymax touts newest formulations for medtech wearables

August 3, 2021 By Chris Newmarker

Dymax Dymax is using MD&M West in Anaheim, Calif. next week to tout its newest formulations for assembling medical device wearables.

The Dymax materials are free from IBOA and TPO, are compatible with common and difficult substrates, and have passed ISO 10993-10 for sensitization and irritation, according to the Torrington, Conn.–based company.

For manufacturers involved with in-vitro diagnostics, Dymax has 1172-M-UR, which joins low-surface-energy substrates like COC/COP and has Ultra-Red fluorescing technology. Additional adhesives slated for display include Dymax’s 1040-M autoclave resistant material for potting and encapsulation and the 215-CTH series of catheter bonders engineered for reliability with excellent adhesion and aging performance.

Dymax will be at booth No. 1701 on Aug. 10–12, 2021.

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].